18794 - Human Photo Toxicity Test
Not Applicable
Completed
- Conditions
- Sunscreening Agents
- Interventions
- Drug: BAY 987517Other: Untreated Skin
- Registration Number
- NCT02751372
- Lead Sponsor
- Bayer
- Brief Summary
To determine the phototoxic potential of a topically applied article in human subjects.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 35
Inclusion Criteria
- Be male or female between the ages of 18 and 60 inclusive;
- Be lightly pigmented (Fitzpatrick Skin Type I, II, III);
- Have read and signed the written Informed Consent Form and have completed a HIPAA Authorization Form in conformance with 45CFR Parts 160 and 164;
- Be in general good health as determined by the subject's medical history and in the discretion of the investigator.
Exclusion Criteria
- Have a visible sunburn;
- Have a history of sun hypersensitivity/photosensitivity or photosensitive dermatoses;
- Must not have a known sensitivity or allergy against any of the active and non-active ingredients of the test product.
- Have a history of allergies or sensitivities to cosmetics, toiletries or any dermatological products.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description BAY 987517 BAY 987517 All subjects are patched . BAY 987517 Untreated Skin All subjects are patched .
- Primary Outcome Measures
Name Time Method Intensity of skin reactions will be evaluated using 5 point grading scale Up to 48 hours
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms of BAY 987517 in phototoxicity testing for sunscreening agents?
How does BAY 987517 compare to standard-of-care sunscreening agents in phototoxicity and efficacy profiles?
Are there specific biomarkers associated with phototoxic response to BAY 987517 in human trials?
What adverse events are reported in phototoxicity trials involving BAY 987517 and how are they managed?
What related compounds or combination therapies are being explored by Bayer for phototoxicity mitigation in sunscreening agents?